Uche Okuu Arunsi is a dedicated PhD Candidate in Oyelere Laboratories, School of Chemistry and Biochemistry, Georgia Institute of Technology, Atlanta, United States. His research focus is on bioorganic chemistry, specifically in the intersection of chemotherapy and immunotherapy. His current research investigates the synergistic potential of combining Deferiprone/Lysine Histone Demethylase Inhibitors (KDMi) with ascorbic acid and antiandrogens to treat prostate and triple-negative breast cancers. He is under the mentorship of Professor Adegboyega Oyelere.
Uche holds a Master’s degree in Cancer Immunology and Biotechnology from the University of Nottingham, where his research explored the role of ZEB1 and CD45-positive cells in vascular endothelial quiescence. His academic foundation in biochemistry was established at Abia State University, Nigeria, where he completed a Bachelor's degree and conducted a thesis on the antiulcerogenic potential of plant extracts in Wistar rats.
A passionate researcher, Uche has co-authored numerous peer-reviewed publications across diverse areas of pharmacology and toxicology, including cancer therapies and toxicological impacts on reproductive health. His work has been featured in journals such as Toxicon, Fundamental and Clinical Pharmacology, and Scientific Reports. He has presented at national and international conferences, receiving recognition for his outstanding contributions.
Uche Okuu Arunsi is a dedicated PhD Candidate in Oyelere Laboratories, School of Chemistry and Biochemistry, Georgia Institute of Technology, Atlanta, United States. His research focus is on bioorganic chemistry, specifically in the intersection of chemotherapy and immunotherapy. His current research investigates the synergistic potential of combining Deferiprone/Lysine Histone Demethylase Inhibitors (KDMi) with ascorbic acid and antiandrogens to treat prostate and triple-negative breast cancers. He is under the mentorship of Professor Adegboyega Oyelere.
Uche holds a Master’s degree in Cancer Immunology and Biotechnology from the University of Nottingham, where his research explored the role of ZEB1 and CD45-positive cells in vascular endothelial quiescence. His academic foundation in biochemistry was established at Abia State University, Nigeria, where he completed a Bachelor's degree and conducted a thesis on the antiulcerogenic potential of plant extracts in Wistar rats.
A passionate researcher, Uche has co-authored numerous peer-reviewed publications across diverse areas of pharmacology and toxicology, including cancer therapies and toxicological impacts on reproductive health. His work has been featured in journals such as Toxicon, Fundamental and Clinical Pharmacology, and Scientific Reports. He has presented at national and international conferences, receiving recognition for his outstanding contributions.